Supply Chain Management main glossary
This is a glossary of key terms used throughout the site.
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
A dose is the quantity of a medication that is administered at a certain time.
Evaluation is the process that attempts to determine as systematically and objectively as possible the relevance, effectiveness, and impact of activities in light of their objectives.
Finished pharmaceutical product
A finished pharmaceutical product (FPP) is the final product after all stages of manufacture, including packaging in its final container and labelling.
Finished product specifications
Finished product specifications are the set of tests and values applicable to a finished pharmaceutical product (FPP), to ensure that every batch is of consistent quality at the time of release and throughout its shelf-life.
In medicines, the term formulation refers to the process in which different chemicals, including the active ingredient, are combined to produce a final pharmaceutical product.
A freight forwarder, forwarder or forwarding agent, is a person or company that organises shipments for individuals or corporations.
Good manufacturing practices
Good manufacturing practices (GMP) is that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorisation. It is designed to minimise the risks involved in any pharmaceutical production.
A health system consists of all organisations, people and actions whose primary intent is to promote, restore or maintain health.
Health system strengthening
Health system strengthening (HSS) can be defined as any combination of initiatives and strategies meant to improve one or more of the functions of a health system with the ultimate aim of improving the whole. Progress in access, coverage, quality, or efficiency of the health services can all lead to better health.